January 2006

J Psychiatry Neurosci 2006;31(1)


Discontinuing treatment for psychiatric disorders
R.T. Joffe


Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology
D.S. Moskowitz, S.N. Young

Review Paper

Brain imaging and cognitive dysfunctions in Huntington’s disease
A. Montoya, B.H. Price, M. Menear, M. Lepage

Research Papers

Antipsychotic drugs cause glial cell line–derived neurotrophic factor secretion from C6 glioma cells
Z. Shao, L.E. Dyck, H. Wang, X.M. Li

Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence
A.J. Dean, J.B. Saunders, R.T. Jones, R.M. Young, J.P. Connor, B.R. Lawford

Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial
N. Grizenko, M. Bhat, G. Schwartz, M. Ter-Stepanian, R. Joober

Psychopharmacology for the Clinician

Managing discontinuation syndrome in patients with dementia
S. Gauthier


2005 Reviewers